Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Blood-Based injection replace steroids for back pain?

NCT ID NCT07036445

Symptom relief Sponsor: Clinique du Sport, Bordeaux Mérignac Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether platelet-rich plasma (PRP), made from a patient's own blood, works as well as steroid injections for long-term relief of leg and back pain caused by a herniated disc. Researchers will follow 200 adults for two years to compare pain and function. PRP may be a safer alternative with fewer serious risks than steroids.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
platelet-rich plasma (PRP) and epidural steroid injection
What this could lead to
If PRP works as well as steroids but with fewer serious side effects, it could offer a safer long-term treatment option for persistent back and leg pain from a herniated disc.
What could go wrong
This is a single-center study with 200 participants, so results may not apply to everyone. PRP is still experimental for this use, and it's unclear if it will match steroids' effectiveness over two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of unilateral resistant LRP associated with a herniated disc on MRI images. (Diagnosis of resistance after 6 weeks of appropriate medical treatment). Exclusion Criteria: * Patients with infections, * Patients who have had previous percutaneous corticosteroid injections, * Patients undergoing systemic corticosteroid treatment, * Patients with immune deficiencies, * Patients who are allergic to the contrast medium used, * Pregnant or breastfeeding patients, * Patients with a history of allergies to anesthetics or corticosteroids, * Anticoagulant treatment or blood disorders, patients on antiplatelet therapy * Taking NSAIDs within two weeks prior to the procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Herniated disc are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Herniated disc

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinique du Sport

    RECRUITING

    Mérignac, 33700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.